Singular seals US deal to roll out 3D medical imaging platform
Singular says three major challenges continue to hobble the US healthcare system - redundant medical imaging, slow disease detection and fragmented access to patient data.
The company's 3D medical imaging platform - dubbed 3DICOM MD - has been purpose-built to solve these issues by streamlining access to medical scans across multiple servers, thereby reducing duplication, saving time, cutting costs and improving outcomes. It has also already been cleared for diagnostic use in the US.
The new contract follows a year-long collaboration with PNS that started with a memorandum of understanding in November last year. The project has now evolved into a full-blown rollout backed by both parties.
The breakthrough deal will see Singular push out its US$800 (A$1230) platforms to 1000 doctors within the PNS network. PNS manages more than 3.7 million patients stretched across Florida, Texas and Puerto Rico.
The deal also attracts an additional success fee of US$500,000 (A$768,000) when PNS signs off on the satisfactory integration of its AI model and centralised image repository.
A successful implementation could potentially leverage PNS's partner network in 30 additional states and open the door to a much larger-scale nationwide rollout.
Singular says the landmark deal is a massive shot in the arm, giving it a solid beachhead in the lucrative US healthcare market ahead of a much bigger national push. The company is eyeing a jaw-dropping US$19 billion (A$29.2B) annual market opportunity, with 1.3 million doctors typically linked to 19 separate managed service organisations.
To support its growth strategy Singular has also locked in firm commitments for a heavily supported $8 million placement at 35 cents per share, which is a modest 4.6 per cent discount on its recent trading average.
The company says the capital raising attracted strong interest from institutional investors and high-net-worth backers, with both PNS and existing investor Marin & Sons tinning up to support the placement.
PNS chief executive officer and founder Dr Jose Pelayo praised the technology as a smarter, more efficient way to fix duplicate imaging.
With a strong war chest, now sitting at nearly $13 million after the latest capital raising, powerful allies and a proven tech platform now gaining traction in the world's largest healthcare market, Singular Health may be about to rewrite the rules on medical imaging – in 3D.
Is your ASX-listed company doing something interesting? Contact:
matt.birney@wanews.com.au
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AU Financial Review
18 minutes ago
- AU Financial Review
Life360 CEO Chris Hulls moves to executive chairman seat
Chris Hulls, the co-founder of Life360, will step down as chief executive of the $8.8 billion family tracking app after nearly two decades, to move into the position of executive chairman. The ASX-listed company, which is based in Silicon Valley, said on Tuesday morning that chief operating officer Lauren Antonoff has been promoted to the chief executive role as part of a succession plan the company said was put into motion nearly two years ago.
ABC News
2 hours ago
- ABC News
Donald Trump extends China's 125pc tariff deadline for another 90 days
Donald Trump has signed an executive order extending a pause in sharply higher US tariffs on Chinese imports for another 90 days, a White House official said. A tariff truce between Beijing and Washington had been set to expire on August 12 at midnight Beijing time (3:01pm AEST), but the Trump administration had hinted the deadline could be extended. The US and China agreed to a 90-day pause on triple-digit tariffs in May, after the trade war sent world markets tumbling. If it is not extended, US tariffs on Chinese goods will shoot up to 145 per cent, with Chinese tariffs on US imports set to hit 125 per cent. On Monday, the US president said Washington had been "dealing very nicely with China". "We'll see what happens. They've been dealing quite nicely. The relationship is very good with President Xi [Jinping] and myself," Mr Trump told reporters. Earlier in the day, Beijing said it was looking to Washington for "positive" trade outcomes. "We hope that the US will work with China to follow the important consensus reached during the phone call between the two heads of state," said Chinese foreign ministry spokesperson Lin Jian in a statement. He added that Beijing also hoped Washington would "strive for positive outcomes on the basis of equality, respect and mutual benefit". Although both sides reached a pact to de-escalate tensions after high-level talks in Geneva in May, their truce has been shaky. In June, key economic officials convened in London as disagreements emerged and US officials accused their counterparts of violating the pact. Policymakers again met in Stockholm last month. Even as both countries appeared to be seeking to push back the reinstatement of duties, US trade envoy Jamieson Greer said last month that Mr Trump would have the "final call" on any such extension. Last week, US Commerce Secretary Howard Lutnick said in an interview that it is likely Mr Trump would further the pause by another 90 days. Mr Trump said in a social media post late on Sunday that he hoped China would "quickly quadruple its soybean orders", adding that this would be a way to balance trade with the United States. For now, fresh US tariffs on Chinese goods this year stand at 30 per cent, while Beijing's corresponding levy on US products is at 10 per cent. Since returning to the presidency in January, Mr Trump has slapped a 10 per cent "reciprocal" tariff on almost all trading partners, aimed at addressing trade practices Washington deemed unfair. This surged to varying, steeper levels last Thursday for dozens of economies. Major partners like the European Union, Japan and South Korea now see a 15 per cent US duty on their products, while the level went as high as 41 per cent for Syria. The "reciprocal" tariffs exclude sectors that have been separately targeted, such as steel and aluminium, and those that are being investigated like pharmaceuticals and semiconductors. Mr Trump has also taken separate aim at individual countries such as Brazil over the trial of former president Jair Bolsonaro, who is accused of planning a coup, and India over its purchase of Russian oil. AFP/ABC
ABC News
11 hours ago
- ABC News
How the United States found itself in a measles 'crisis'
There is a high risk the US will lose its measles elimination status — that's the stark warning from the country's health experts. The viral outbreak has led to broader questions over radical changes in vaccine policy under the leadership of Health Secretary Robert F Kennedy Jr. North America correspondent Kamin Gock reports.
